Reporting endometrial cells in women 40 years and older: Assessing the clinical usefulness of Bethesda 2001

American Journal of Clinical Pathology

Volumn 123, Issue 4, 2005, Pages 571-575

  Simsir, Aylin ^a   Carter, William ^b   Elgert, Paul ^a   Cangiarella, Joan ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bethesda System; Cervicovaginal smears; Endometrial cells; Hormone replacement therapy; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; CELL TYPE; COMPLEX ATYPICAL ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; ENDOMETRIUM HYPERPLASIA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; VAGINA BLEEDING;

EID: 15744396515     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/LJRD8JGJ7E5ERBUW     Document Type: Article

References (27)

1. Kurman RJ, Solomon D. The Bethesda System for Reporting Cervical and Vaginal Cytologic Diagnosis. New York, NY: Springer-Verlag; 1994:62-63.
2. Cherkis RC, Patten SF Jr, Andrews TJ, et al. Significance of normal endometrial cells detected by cervical cytology. Obstet Gynecol. 1988;71:242-244.
3. Gondos B, King EB. Significance of endometrial cells in cervicovaginal smears. Ann Clin Lab Sci. 1977;21:432-434.
4. McGowan L. The current efficacy of the cervical-vaginal cytosmear to detect endometrial cancer. Acta Cytol. 1964;8:434-435.
5. Yancey M, Magelssen D, Demaurez A, et al. Classification of endometrial cells on cervical cytology. Obstet Gynecol. 1990;76:1000-1005.
6. Zucker PK, Kasdon EJ, Feldstein ML. The validity of Pap smear parameters as predictors of endometrial pathology in menopausal women. Cancer. 1985;56:2256-2263.
7. Ng AB, Reagan JW, Hawliczek S, et al. Significance of endometrial cells in the detection of endometrial carcinoma and its precursors. Acta Cytol. 1974;18:356-361.
8. Gomez-Fernandez CR, Ganjei-Azar P, Capote-Dishaw J, et al. Reporting normal endometrial cells in Pap smears: an outcome appraisal. Gynecol Oncol. 1999;74:381-384.
9. Solomon D, Davey D, Kurman R, et al, and Forum Group Members, Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
10. Karim BO, Burroughs FH, Rosenthal DL, et al. Endometrial-type cells in cervico-vaginal smears: clinical significance and cytopathologic correlates. Diagn Cytopathol. 2002;26:123-127.
11. Mount SL, Wegner EK, Eltabbakh GH, et al. Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy. Obstet Gynecol. 2002;100:445-450.
12. Sarode VR, Rader AE, Rose PG, et al. Significance of cytologically normal endometrial cells in cervical smears from postmenopausal women. Acta Cytol. 2001;45:153-156.
13. Abadi MA, Barakat RR, Saigo PE. Effects of tamoxifen on cervicovaginal smears from patients with breast cancer. Acta Cytol. 2000;44:141-146.
14. Ashfaq R, Sharma S, Dulley T, et al. Clinical relevance of benign endometrial cells in postmenopausal women. Diagn Cytopathol. 2001;25:235-238.
15. Chang A, Sandweiss L, Bose S. Cytologically benign endometrial cells in the Papanicolaou smears of postmenopausal women. Gynecol Oncol. 2001;80:37-43.
16. Wu HH, Schuetz MJ III, Cramer H. Significance of benign endometrial cells in Pap smears from postmenopausal women. J Reprod Med. 2001;46:795-798.
17. Brogi E, Tambouret R, Bell DA. Classification of benign endometrial glandular cells in cervical smears from postmenopausal women. Cancer. 2002;96:60-66.
18. DuBeshter B, Warshol DP, Angel C, et al. Endometrial carcinoma: the relevance of cervical cytology. Obstet Gynecol. 1991;77:458-462.
19. Kerpsack JT, Finan MA, Kline RC. Correlation between endometrial cells on Papanicolaou smear and endometrial carcinoma. South Med J. 1998;91:749-752.
20. Reagan JW. Cytologic aspects of endometrial neoplasia [proceedings]. Acta Cytol. 1980;24:488-489.
21. Bean S, Connolly K, Roberson J, et al. Incidence and clinical significance of normal endometrial cells in patients 40 years and older [abstract]. Acta Cytol. 2004;48:677.
22. Papillo JL, Harmon ML, Mount SL, et al. Reporting of endometrial cells in women 40-50 results in increased endometrial biopsies with low yield [abstract]. Acta Cytol. 2004;48:677-678.
23. Long KD, Biscotti C. An analysis of the Bethesda System 2001 guideline for reporting benign endometrial cells [abstract]. Acta Cytol. 2004;48:676-677.
24. Saad RS, Mahdavy M, Takei H, et al. Endometrial cells in cervical specimens of women > 40 years of age [abstract]. Acta Cytol. 2004;48:678-679.
25. Ely KA, Bregman S, Arnott CK. Clinical significance of reporting endometrial cells in patients over the age of 40 and its influence on the decision to biopsy [abstract]. Acta Cytol. 2004;48:678.
26. Eddy G, Wojtowycz MA, Piraino PS, et al. Papanicolaou smears by the Bethesda System in endometrial malignancy: utility and prognostic importance. Obstet Gynecol. 1997;90:999-1003.
27. Montz FJM. Significance of "normal" endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy. Gynecol Oncol. 2001;81:33-39.